Balaji Amines credit ratios

·ChemicalsChart ›
ProfitabilityGrowthCreditLiquidityWorking capitalDividend yieldDuPontCAGR
Per cent unless marked ×
Tap a line for its trendLast 12Mto Jun 2026FY26Mar 2026FY25Mar 2025FY24Mar 2024FY23Mar 2023FY22 and earlierAlpha Plus
13313310.619.757.6
FY22 and earlierEvery year the company has filed comes with Alpha Plus.
−138−138−343−320−251
0.06×0.06×0.01×0.01×0.03×
−0.06×−0.06×−0.17×−0.17×−0.15×
0.50×0.50×0.05×0.06×0.09×
−0.42×−0.52×−1.48×−0.99×−0.41×
38.93×38.93×49.68×43.21×47.07×
5.8%5.8%0.5%1.0%3.3%
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

BALAMINES₹1,848.80

Balaji Amines Ltd.

· Chemicals
₹ CrorePeersALKYLAMINEDEEPAKNTRTECILCHEMAETHERACIELLENGHCLGNFCMcap ₹5,990 Cr
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Total Debt57.619.710.6132.9132.9
Net Debt-251.4-320.1-342.9-138.5-138.5
Total Debt/Equity0.030.010.010.060.06
Net Debt/Equity-0.15-0.17-0.17-0.06-0.06
Total Debt/EBITDA0.090.060.050.500.50
Net Debt/EBITDA-0.41-0.99-1.48-0.52-0.42
Interest Coverage (EBIT/Interest)47.0743.2149.6838.9338.93
Total Debt/Total Capital %3.281.030.525.825.82
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.